These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17214319)

  • 1. Revisiting the role of p53 in primary and secondary glioblastomas.
    Nagpal J; Jamoona A; Gulati ND; Mohan A; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2006; 26(6C):4633-9. PubMed ID: 17214319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 and p21 in primary glioblastomas.
    Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
    Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
    Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging characteristics in subgroup of GBMs with p53 overexpression.
    Mut M; Turba UC; Botella AC; Baskurt E; Lopes MB; Shaffrey ME
    J Neuroimaging; 2007 Apr; 17(2):168-74. PubMed ID: 17441839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.
    Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H
    J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M; Menghi F; Bruzzone MG; De Simone T; Valletta L; Pollo B; Bissola L; Silvani A; Bianchessi D; D'Incerti L; Filippini G; Broggi G; Boiardi A; Finocchiaro G
    Clin Cancer Res; 2007 May; 13(9):2606-13. PubMed ID: 17473190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and programmed cell death: role of p53 protein in high and low grade astrocytoma.
    Facoetti A; Ranza E; Nano R
    Anticancer Res; 2008; 28(1A):15-9. PubMed ID: 18383819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of p53 mutations on prognosis of patients with glioblastoma.
    Shiraishi S; Tada K; Nakamura H; Makino K; Kochi M; Saya H; Kuratsu J; Ushio Y
    Cancer; 2002 Jul; 95(2):249-57. PubMed ID: 12124823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.
    Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G
    Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
    Nobusawa S; Watanabe T; Kleihues P; Ohgaki H
    Clin Cancer Res; 2009 Oct; 15(19):6002-7. PubMed ID: 19755387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of radiographically defined de novo glioblastoma multiforme.
    Tortosa A; Ino Y; Odell N; Swilley S; Sasaki H; Louis DN; Henson JW
    Neuropathol Appl Neurobiol; 2000 Dec; 26(6):544-52. PubMed ID: 11123721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology.
    Necesalová E; Vranová V; Kuglík P; Cejpek P; Jarosová M; Pesáková M; Relichová J; Veselská R
    Neoplasma; 2007; 54(3):212-8. PubMed ID: 17447852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma multiforme in skin: a report of 2 cases and review of the literature.
    Mentrikoski M; Johnson MD; Korones DN; Scott GA
    Am J Dermatopathol; 2008 Aug; 30(4):381-4. PubMed ID: 18645311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
    Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
    Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.
    Tohma Y; Gratas C; Van Meir EG; Desbaillets I; Tenan M; Tachibana O; Kleihues P; Ohgaki H
    J Neuropathol Exp Neurol; 1998 Mar; 57(3):239-45. PubMed ID: 9600216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.
    Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G
    Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.